Jordi Xiol 10 months ago
Some me-toos and some long shots, but two stand out:
- $NVS $IONS Pelacarsen cardiovascular outcomes trial. Lp(a) has been associated with CV disease since the 1970s. First of a highly anticipated class of medicines
- MORF-057 Ph2b in UC. Is $LLY on a roll also in BD and can orals replace biologics
add a skeleton here at some point